LA40-0 Supplementary vocabulary
LA40-0 For radiotherapy reagents
LA40-0 is a supplementary CPV code meaning For radiotherapy reagents. It is added alongside a main CPV code to qualify it - a material, a purpose, a target group - and never replaces it.
This CPV code in every EU language
For radiotherapy reagents
English (EN)
За реактиви за радиотерапия
Български (BG)
Pro radioterapeutická činidla
Čeština (CS)
Til radioterapireagenser
Dansk (DA)
Für radiotherapeutische Reagenzien
Deutsch (DE)
Για αντιδραστήρια ακτινοθεραπείας
Ελληνικά (EL)
Para reactivos de radioterapia
Español (ES)
Radioteraapia reagentide jaoks
Eesti (ET)
Sädehoitoreagensseihin
Suomi (FI)
Pour réactifs de radiothérapie
Français (FR)
Za radioterapeutske reagense
Hrvatski (HR)
Radioterápiai reagensekhez
Magyar (HU)
Per reagenti di radioterapia
Italiano (IT)
Radioterapijos reagentams
Lietuvių (LT)
Radioterapijas reaģentiem
Latviešu (LV)
Għar-reaġenti tar-radjoterapija
Malti (MT)
Voor radiotherapeutische reagentia
Nederlands (NL)
Do odczynników radioterapii
Polski (PL)
Para reagentes de radioterapia
Português (PT)
Pentru reactivi de radioterapie
Română (RO)
Pre rádioterapeutické činidlá
Slovenčina (SK)
Za radioterapevtske reagente
Slovenščina (SL)
För radioterapeutiska reagens
Svenska (SV)
Commission Regulation (EC) No 213/2008 - official wording for LA40-0.
Section LA (55)
| Code | Description |
|---|---|
| LA01-3 | For anaesthetics |
| LA02-6 | For artificial-kidney treatment |
| LA03-9 | For autopsy |
| LA04-2 | For bronchial endoscopy |
| LA05-5 | For burns |
| LA06-8 | For cytostatic treatment |
| LA07-1 | For diagnostic radiology |
| LA08-4 | For dietary use |
| LA09-7 | For disinfection |
| LA10-0 | For dispensary use |
| LA11-3 | For endovascular use |
| LA12-6 | For gynaecology |
| LA13-9 | For haemodialysis |
| LA14-2 | For haemodynamics |
| LA15-5 | For heart surgery |
| LA16-8 | For hospital use |
| LA17-1 | For immunology |
| LA18-4 | For infusion |
| LA19-7 | For injection |
| LA20-0 | For intensive-care use |
| LA21-3 | For laboratory use |
| LA22-6 | For medical personnel |
| LA23-9 | For medical use |
| LA24-2 | For neuro-angiographical use |